Asset profile
Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company. It focuses on developing novel drug candidates for immuno-inflammatory diseases using its proprietary KINect drug discovery platform. The company's pipeline consists of the following key p…
Nothing scheduled in this window.
Newest first.
| Registry ID | Phase | Status | Primary completion | Enrollment | Sites |
|---|---|---|---|---|---|
| NCT07011706 | Phase 2 | Active, not recruiting | Sep 21, 2026 | 110 | 53 of 60 sites in the United States |
Other drugs and candidates from the same company tracked in this sector.